EnGro Corporation (S44) H2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H2 2024 earnings summary
28 Oct, 2026Executive summary
FY2024 revenue rose 15.6% YoY to S$185.4m, led by construction demand in Singapore and Malaysia; net profit was S$0.2m after a S$4.7m one-time, non-cash impairment at a China GGBS JV.
Profit attributable to owners was S$1.1m, versus a S$6.3m loss in FY2023; basic EPS was 0.92 cents versus a 5.34-cent loss.
Financial highlights
Revenue increased to S$185.4m from S$160.4m; cement and building materials contributed S$175.0m, specialty polymer S$10.1m, and food and beverage S$0.3m.
Gross profit was S$50.6m; operating profit was S$3.9m, versus an operating loss of S$0.4m in FY2023.
Profit before tax was S$1.2m; net profit was S$0.2m, compared with a FY2023 net loss of S$5.6m.
Other income was S$4.8m and net fair-value gains on financial assets were S$1.9m; share of associate and JV losses was S$3.3m.
Outlook and guidance
FY2025 profitability is expected to be maintained, with cautious optimism supported by core business opportunities.
Singapore construction demand is projected at S$47bn–S$53bn in 2025; medium-term demand is forecast at S$39bn–S$46bn annually for 2026–2029.
Singapore PBFC supply for Changi T5 is expected to begin in mid-2025; the Pulau Punggol Timor batching plant commenced production in January 2025.
Indonesia polymer growth plans include two-wheeler projects targeted for mass production in Q2 2025, with automation and local-content advantages supporting market expansion.
China GGBS plans prioritize cost optimization, operational efficiency and higher-value products amid continuing market adjustment.
Latest events from EnGro Corporation
- Revenue rose 6.5%, but profit after tax halved as China and investment income weakened.S44
H1 2023 - Revenue grew 20.6%, but China weakness and VC marks drove a S$5.6m net loss.S44
H2 2023 - Revenue grew 21.3%, but one-off and investment losses cut net profit to $20k.S44
H1 2024 - Revenue growth and fair-value gains lifted H1 profit; operating and market risks persist.S44
H1 2025 - Revenue rose 33.5%; investment gains lifted profit as supply-chain disruptions persisted.S44
H2 2025 - H1 profit surged on an unrealised investment gain as core demand diverged by segment.S44
H1 2026